| 摘要 |
<p>The present invention relates to synthesised RNAs, more specific short interfering RNAs (siRNAs) that are able to modulate the expression of Tissue Factor (TF), as well as to a pharmaceutical preparation comprising the synthesised siRNA(s) and use thereof.</p> |
